The ApoA-I peptide mimetic 5A protects against atherosclerosis in apoE deficient mice

被引：0
|
作者：
Amar, Marcelo J. [1 ]
Basso, Federica [1 ]
Demosky, Steve [1 ]
Stonick, John [1 ]
Remaley, Alan T. [1 ]
机构：
[1] NHLBI, NIH, Bethesda, MD 20892 USA
来源：
CIRCULATION | 2006年 / 114卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：23 / 23
页数：1
相关论文
共 50 条
  • [1] Mechanism for hypertriglyceridemia caused by treatment with apoA-I or the 5a apoA-I mimetic peptide
    Amar, Marcelo J.
    Pryor, Milton
    Demosky, Steve
    Stonik, John
    Remaley, Alan T.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (06) : E58 - E59
  • [2] Mechanism for Atheroprotection in Mice by 5A, a bi-helical ApoA-I Mimetic Peptide
    Amar, Marcelo J.
    Demosky, Steve
    Stonick, John
    Voogt, Jason
    Turner, Scott
    Nigora, Mukhamedova
    Sviridov, Dmitri
    Remaley, Alan T.
    CIRCULATION, 2008, 118 (18) : S410 - S410
  • [3] Gene transfer of an ApoA-I mimetic peptide reduces atherosclerosis in mice
    Bodary, PF
    Shen, YC
    Westrick, RJ
    Lalwani, ND
    Drake, SL
    Dasseux, JLH
    Eitzman, DT
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 465A - 466A
  • [4] A novel apoA-I mimetic peptide suppresses atherosclerosis by promoting physiological HDL function in apoE-/-mice
    Gou, Sanhu
    Wang, Li
    Zhong, Chao
    Chen, Xinyue
    Ouyang, Xu
    Li, Beibei
    Bao, Guangjun
    Liu, Hui
    Zhang, Yun
    Ni, Jingman
    BRITISH JOURNAL OF PHARMACOLOGY, 2020, 177 (20) : 4627 - 4644
  • [5] ApoA-I mimetic peptide 5A boosts remyelination by promoting myelin debris clearance
    Vanherle, S.
    Dierckx, T.
    Loix, M.
    Jorissen, W.
    Gervois, P.
    Lambrichts, I.
    Dehairs, J.
    Swinnen, J.
    Mulder, M.
    Remaley, A.
    Haidar, M.
    Bogie, J.
    Hendriks, J.
    GLIA, 2021, 69 : E528 - E528
  • [6] Lentiviral transduction of human apoA-I and apoA-I milano into hematopoietic progenitor cells reduces atherosclerosis in apoE-deficient mice
    Su, Yan Ru
    Blakemore, John L.
    Zhang, Youmin
    Linton, MacRae F.
    Fazio, Sergio
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (06) : E63 - E63
  • [7] The ApoA-I mimetic peptide 5A enhances remyelination by promoting clearance and degradation of myelin debris
    Vanherle, Sam
    Jorissen, Winde
    Dierckx, Tess
    Loix, Melanie
    Grajchen, Elien
    Mingneau, Fleur
    Guns, Jeroen
    Gervois, Pascal
    Lambrichts, Ivo
    Dehairs, Jonas
    Swinnen, Johannes, V
    Mulder, Monique T.
    Remaley, Alan T.
    Haidar, Mansour
    Hendriks, Jerome J. A.
    Bogie, Jeroen J. F.
    CELL REPORTS, 2022, 41 (06):
  • [8] The 5A apolipoprotein A-I (apoA-I) mimetic peptide ameliorates experimental colitis by regulating monocyte infiltration
    Nowacki, Tobias M.
    Remaley, Alan T.
    Bettenworth, Dominik
    Eisenblaetter, Michel
    Vowinkel, Thorsten
    Becker, Felix
    Vogl, Thomas
    Roth, Johannes
    Tietge, Uwe J.
    Luegering, Andreas
    Heidemann, Jan
    Nofer, Jerzy-Roch
    BRITISH JOURNAL OF PHARMACOLOGY, 2016, 173 (18) : 2780 - 2792
  • [9] Recent progress in the development of apoA-I and apoE mimetic therapies
    Anantharamaiah, G. M.
    Garber, David W.
    CLINICAL LIPIDOLOGY, 2013, 8 (03) : 265 - 268
  • [10] FAMP, a Novel ApoA-I Mimetic Peptide, Suppresses Aortic Plaque Formation Through Promotion of Biological HDL Function in ApoE-Deficient Mice
    Uehara, Yoshinari
    Ando, Setsuko
    Yahiro, Eiji
    Oniki, Kosuke
    Ayaori, Makoto
    Abe, Satomi
    Kawachi, Emi
    Zhang, Bo
    Shioi, Seijiro
    Tanigawa, Hiroyuki
    Imaizumi, Satoshi
    Miura, Shin-ichiro
    Saku, Keijiro
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2013, 2 (03):
12345